74 results for "null null"
Showing 61–74 · 2.03 seconds · RSS
-
Journal Article Full text
Role of CYP2B in Phenobarbital-Induced Hepatocyte Proliferation in Mice
…proliferation. This hypothesis was tested here by using a Cyp2a(4/5)bgs-null (null) mouse model in which all Cyp2b genes are deleted. Adult male and female wild-type (WT) and null mice were treated intraperitoneally with PB at 50 mg/kg once daily for 5 successive days and tested on day 6. The…
-
Journal Article Full text
How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment
…this medication is less potent in patients without functional LDLR (e.g., null/null variant). Novel therapies that are expected to become available in the near future focused on inhibition of another major regulatory protein in lipid metabolism (angiopoietin-like 3 (ANGPTL3)) might dramatically…
-
Journal Article Full text
Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
…Myc and Kras(G12D) into the genome in liver cells from conditional Trp53 null/null mice (pTMK/Trp53(−/−)). Flow cytometry and immunohistochemistry were used to assess the changes in immune cells in the tumor microenvironment. An ex vivo coculture assay was performed to test the inhibitory effects…
-
Journal Article Full text
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis
…investigate the functional role of lumican in hepatic fibrosis, lumican null (Null) and wild-type (WT) littermates were administered carbon tetrachloride intra-peritoneally. Serum and liver tissue were analyzed for indices of liver injury, fibrosis, matrix turnover, and proliferation. Hepatic…
-
Journal Article Full text
Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction
…dysfunction, we compared the LVs of 6–9- and 15–18-mo-old WT and MMP-9 null (Null) mice. All groups showed similar LV function by echocardiography, indicating that dysfunction had not yet developed in the older group. Myocyte nuclei numbers and cross-sectional areas increased in both WT and Null…
-
Journal Article Full text
Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.
…the development of pulmonary emphysema. An alpha 1AT gene is defined as "Null" when no alpha 1AT in serum is attributed to that alpha 1AT gene. Although all alpha 1AT Null genes have identical phenotypic consequences (i.e. no detectable alpha 1AT in the serum), different genotypic mechanisms can…
-
Journal Article Full text
Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes.
…1AT genes. However, when used to evaluate a very rare family carrying a null allele, these four oligonucleotide probes misidentified the "at risk" null-null and S null phenotypes as "not at risk" MM and SM combinations. These observations indicate that oligonucleotide gene probes yielded reliable…
-
Journal Article Full text
Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD
…childhood and adolescence for the overall cohort. Patients with two null PKHD1 variants had larger first documented haeTKV values than children with missense variants (median (IQR) haeTKV 793 (450–1098) ml/m in Null/null, 403 (260–538) ml/m in Null/mis, 230 (169–357) ml/m in Mis/mis). In the…
-
Journal Article Full text
Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis
…homozygous FH (HoFH), it varied dramatically. Pediatric patients with the null/null variant may respond to the treatment. PCSK9 inhibitors were generally well tolerated within most pediatric patients, in line with previous studies among adult populations. Conclusions: The PCSK9 inhibitors…
-
Journal Article Full text
WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk
…WWOX variants from our cohort and the literature were coded as either null or missense, allowing individuals to be classified into one of three genotype classes: (1) null/null, (2) null/missense, (3) missense/missense. Differences in survival outcome were estimated using the Kaplan–Meier method…
-
Journal Article Full text
Focal adhesion kinase inhibition enhances response to checkpoint immunotherapy in hepatocellular carcinoma
…integration of Myc and Kras(G12D) oncogenes into hepatocytes of Trp53 null/null mice (pTMK/Trp53(-/-)), coupled with subcutaneous xenograft models. These models were treated with FAK inhibitor IN10018 as monotherapy or in combination with anti-PD-1 immunotherapy. RESULTS: FAK was highly expressed…
-
Journal Article Full text
Generation of a Tph2 Conditional Knockout Mouse Line for Time- and Tissue-Specific Depletion of Brain Serotonin
…of the third exon of Tph2 gene results in the production of a Tph2 (null) allele in which we observed the near-complete loss of brain serotonin, as well as the growth defects and perinatal lethality observed in serotonin conventional knockouts. We also revealed that in mice harbouring the Tph2…
-
Journal Article Full text
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
…EAS target LDL-C while receiving PCSK9i; genotype analysis suggested LDLR-null/null patients were most refractory to PCSK9i. CONCLUSION: Response to PCSK9i was minimal in this cohort of patients with HoFH. No patients achieved EAS LDL-C targets, and most failed to reach the EAS-recommended 15%…
-
Journal Article Full text
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial
BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is a genetic disease characterized by high levels of low-density lipoprotein cholesterol (LDL-C) present from birth, leading to early-onset and progressive atherosclerotic cardiovascular disease. Early treatment initiation is crucial for…